SCHEMBL4767800

SCHEMBL4767800

COc1cccc(C2CC2C(=O)Nc2sc3c(c2C#N)CCNC3)c1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 6/20 0.42
MAPT P10636 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HTT P42858 1/20 0.42
RECQL P46063 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.40
TP53 P04637 1/20 0.38
HPGD P15428 2/20 0.38
LMNA P02545 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TGFBR1 P36897 2/20 0.37
MGAM O43451 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2894804 0.92 NPC1 (0.49) POLBMEN1KMT2ANPC1ALDH1A1
SCHEMBL4766464 0.91 POLB (0.48) POLBMEN1KMT2ANPC1ALDH1A1
SCHEMBL4766038 0.91 POLB (0.48) POLBMEN1KMT2ANPC1ALDH1A1
SCHEMBL4960897 0.89 ALDH1A1 (0.43) POLBMEN1KMT2ANPC1ALDH1A1
SCHEMBL4775000 0.87 ALDH1A1 (0.45) POLBMEN1KMT2ANPC1ALDH1A1
SCHEMBL4769353 0.86 POLB (0.50) POLBMEN1KMT2ANPC1ALDH1A1
SCHEMBL4771906 0.86 POLB (0.44) POLBMEN1KMT2ANPC1ALDH1A1
SCHEMBL4961167 0.85 ALDH1A1 (0.45) POLBMEN1KMT2ANPC1ALDH1A1
SCHEMBL4771021 0.84 TGFBR1 (0.48) POLBMEN1KMT2ANPC1ALDH1A1
SCHEMBL4776053 0.84 ALDH1A1 (0.44) POLBMEN1KMT2ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893618-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER Nycomed GmbH (DE) 2008-03-05 EP disclosed
WO-2006125815-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER NYCOMED GMBH (DE) 2006-11-30 WO disclosed